EUCTR2015-001550-14-DK进行中（未招募）1 期
Extracorporeal Photopheresis Treatment in steroid refractory acute and chronic Graft versus Host Disease
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with acute or chronic GVHD, that do not respond sufficiently to glucocorticoids.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 22
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 8
排除标准
- •Patients with contraindications for extracorporeal photopheresis.
- •Patients with relapse of primary hematologic disease or activity in this.
研究者
相似试验
已完成
2 期
Extracorporeal Photopheresis for Acute Graft Versus Host DiseaseGraft Versus Host DiseaseStem Cell TransplantationCancerNCT00179855Ann & Robert H Lurie Children's Hospital of Chicago10
已完成
不适用
Evaluation of the efficacy of external steroid in the treatment of so-called "diaper dermatitis" in elderly patients.diaper dermatitisJPRN-UMIN000008794on-Profit Organization Health Institute Research of Skin100
已完成
不适用
To determine the efficacy of subacromial bursa corticosteroid injection in stroke patients with periarticular shouder disorder.Diseases of the musculo-skeletal system and connective tissueKCT0000104Ajou University Hospital60
进行中（未招募）
3 期
Extracorporeal Photopheresis for Medicare Recipients of Lung AllograftsBronchiolitis Obliterans Syndrome (BOS)NCT02181257Washington University School of Medicine280
进行中（未招募）
不适用
Steroid injection in esophageal radiation stricturesRadiation induced esophageal stricturesMedDRA version: 14.1Level: LLTClassification code 10048900Term: Radiation esophagitisSystem Organ Class: 10022117 - Injury, poisoning and procedural complicationsMedDRA version: 14.1Level: LLTClassification code 10030195Term: Oesophageal stenosis acquiredSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2012-001502-26-PTInstituto Português de Oncologia de Lisboa Francisco Gentil, E.P.E.